CR2 and metastatic malignant neoplasm: Another elegant study showed that an engineering antibody composed by CR2 (CD21) and Fc region of IgG1 binds C3d deposits on tumor cells and enhanced CDC activation via the Fc portion, and mediates the recognization and recruitment of effector immune cells to metastatic cancer cells [123].